With antimicrobial-resistant gonorrhoea now an urgent health threat, requiring improved antibiotic stewardship, one option frequently proposed is laboratory-guided recycling of older antibiotics (Lewis (STI); Ison & Unemo (STI); A new kind of treatment for gonorrhoea? (STI/blogs)). Lewis (STI) alludes to the potential use of floroquinolone therapy – specifically in respect to the oropharyngx, which is […]
A new kind of treatment for multi-resistant gonorrhoea?
Recent research at York University (Ward & Lynam (W&L)), UK, suggests the possible efficacity of carbon monoxide-releasing molecules as an antimicrobial against gonorrhoea. The work is at an early stage – but the urgency of our current situation lends it a heightened interest. Growing resistance of Neisseria gonorrhoeae (Ng) to the last-defence antibiotic treatments (Lewis/STIs) […]
Could Chlamydia treatment failure be the result of genital contamination from persistent gut infection
The persistence of Chlamydia trachomatis (Ct) infection in treated patients is generally attributed either to re-infection or poor treatment adherence. To some, however, the evidence has suggested the operation of an additional factor – such as treatment failure (STIs/ Goetz & Bruisten; STIs/ Pitt & Ison; STIs/ Horner). A recent study (Rank & Yeruva (R&Y)) […]
What clinical evidence is there for the association of gonorrhoea cephalosporin resistance with treatment failure?
Earlier blogs have featured the disquieting propensity of neisseria gonorrhoea to evolve resistance to every known line of treatment (https://blogs.bmj.com/sti/category/gonorrhoea/). Surveillance data indicate the prevalence of the infection in core populations, and the importance of focussing treatment on them ( http://sti.bmj.com/content/85/5/317.abstract?sid=c28b9898-65c9-4548-a10e-9f6ebade86f9); at the same time this is precisely the strategy most likely to disseminate resistance […]